Dr Frank T Vertosick, MD | |
380 W Chestnut St, Suite 101, Washington, PA 15301-4657 | |
(724) 228-1414 | |
(724) 228-8579 |
Full Name | Dr Frank T Vertosick |
---|---|
Gender | Male |
Speciality | Neurological Surgery |
Location | 380 W Chestnut St, Washington, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1750369856 | NPI | - | NPPES |
0089167000 | Medicaid | WV | |
0217205 | Medicaid | OH | |
0011277390012 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | MD027716E (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Frank T Vertosick, MD 380 W Chestnut St, Suite 101, Washington, PA 15301-4657 Ph: (724) 228-1414 | Dr Frank T Vertosick, MD 380 W Chestnut St, Suite 101, Washington, PA 15301-4657 Ph: (724) 228-1414 |
News Archive
Though the cause of Alzheimer's disease still is unknown, recent studies have implicated three proteins strongly in its onset. New research from the University of Alabama at Birmingham, the Gladstone Institutes and the Baylor College of Medicine indicates that interactions between those three proteins might lead to brain dysfunction and AD in a mouse model of the disease.
The University of California, Irvine School of Medicine has agreed to use web-based digital whole slide imaging developed by MAggPI in the teaching of medical students. In this collaboration, diagnostic-quality, expert-curated digital images of normal and diseased tissue will be incorporated in the teaching of histology and pathology to medical students at UCI.
Oncolytics Biotech Inc. announced today that enrollment has begun in a 2-Arm randomized Phase II study of carboplatin, paclitaxel plus REOLYSIN versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer.
Cumberland Pharmaceuticals Inc. announced today that data from two key clinical trials for Caldolor®, an intravenous formulation of ibuprofen approved for treatment of pain and fever in adults, will be presented at the American Academy of Pain Management's (AAPM) 20th Annual Clinical Meeting to be held in Phoenix, Ariz., on October 8-11, 2009.
NinePoint Medical, Inc., an emerging leader in the development of in vivo pathology devices, today announced it has been awarded a grant of approximately $250,000 from the Qualifying Therapeutic Discovery Project (QTDP) Program. The QTDP's grants and tax credits are provided under the new section 48D of the Internal Revenue Code (IRC), enacted as part of the Patient Protection and Affordable Care Act of 2010.
› Verified 3 days ago
Donald M Whiting, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 380 W Chestnut St Ste 101, Washington, PA 15301 Phone: 724-228-1414 Fax: 724-228-8579 | |
Nestor D Tomycz, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 380 W Chestnut St Ste 101, Washington, PA 15301 Phone: 724-228-1414 Fax: 724-228-8579 | |
Edward Richard Prostko, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 380 W Chestnut St Ste 101, Washington, PA 15301 Phone: 724-228-1414 Fax: 724-228-8579 |